Stockscreener 앱 받기
1.10
6.80%
0.07
시장 영업 전:
1.09
-0.01
-0.91%
Bluejay Diagnostics Inc 주식(BJDX)의 최신 뉴스
Bluejay Diagnostics Inc (BJDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BJDX|Bluejay Diagnostics Inc|Price:1.030|Chg%:-0.110 - TradingKey
Bluejay Diagnostics Inc (BJDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bluejay Diagnostics Inc (BJDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bluejay Diagnostics Inc (BJDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Bluejay Diagnostics Inc (BJDX) Balance Sheet - TradingKey
Bluejay Diagnostics Inc (BJDX) Income Statement - TradingKey
Bluejay Diagnostics, Inc. Revenue Breakdown – NASDAQ:BJDX - TradingView
Bluejay Diagnostics Inc (BJDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% owner - Bitget
Form 4 Bluejay Diagnostics Inc For: 22 July By Investing.com - Investing.com South Africa
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study - TipRanks
Bank of America drops below 10% stake in Bluejay Diagnostics, Inc. (BJDX) - Stock Titan
Bluejay Diagnostics, Inc. (BJDX) stock price, news, quote and history - Yahoo Finance UK
Bluejay Diagnostics, Inc. (BJDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of America details Bluejay Diagnostics, Inc. (BJDX) insider stake - Stock Titan
Bluejay completes 750-patient sepsis study - grafa.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study - marketscreener.com
Bluejay completes enrollment in sepsis diagnostic study By Investing.com - Investing.com Nigeria
Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study - TradingView
Bluejay completes enrollment in sepsis diagnostic study - Investing.com
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Validation Study Ahead of Schedule - Quiver Quantitative
Bluejay's sepsis study enrolls 750 patients ahead of schedule - Stock Titan
What's going on with Bluejay Diagnostics shares on Wednesday? - MSN
HRT FINANCIAL LP Acquires 92,055 Shares in Bluejay Diagnostics I - GuruFocus
BJDX Stock Pulls Back As Volatility Cools And Cash Runway Stands Out - StocksToTrade
BJDX Stock Crafts Tight Range After Big Spike - StocksToTrade
BJDX Stock Pulls Back As Traders Watch Key Support - timothysykes.com
Insider Sell: Financial Hrt Sells Shares of Bluejay Diagnostics Inc (BJDX) - GuruFocus
Form 4 Bluejay Diagnostics Inc For: 13 July By Investing.com - Investing.com Canada
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock - Investing.com
HRT Financial LP sells $48,913 in Bluejay Diagnostics stock By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) holder HRT Financial reports net share buying and selling - Stock Titan
[Form 3] Bluejay Diagnostics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
BJDX Q4 2023 Earnings: Wide EPS Miss and No Revenue, Yet Stock Gains 3.57%Margin Expansion Trends - dars.gov.et
Form 4 Bluejay Diagnostics Inc For: 10 July By Investing.com - Investing.com Nigeria
Bluejay Diagnostics (NASDAQ: BJDX) shows Bank of America entities as 10% owners - Stock Titan
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) sees 8 shares reported by Bank of America - Stock Titan
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Cash Runway - StocksToTrade
BJDX Stock Slides As Traders Gauge Cash Runway And Volatility - timothysykes.com
BJDX Stock Pulls Back As Traders Eye Support Levels - StocksToTrade
BJDX Stock Slides As Traders Study Volatile Chart - timothysykes.com
BJDX Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
Bluejay Diagnostics stock rally meets a June warrant wall after pre-market churn - TechStock²
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BJDX Stock Slides As Traders Watch Support Levels - timothysykes.com
BJDX Q4 2023 Earnings: EPS Misses Estimates; No Revenue Reported, Stock DeclinesEarnings Season Preview - dars.gov.et
Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics - TipRanks
Market Movers | Winners: TRNR, DCOY, ATLN | Losers: BJDX, EVMN, CELZ - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Bluejay Diagnostics, Inc. SEC Filing (Jun 29, 2026) - Stock Titan
Bluejay Diagnostics (BJDX) Falls 11.5% as Selling Pressure Intensifies; Support at $2.78 in FocusTrend Continuation Trade - dars.gov.et
Bluejay Diagnostics (BJDX) registers 11.2M resale shares; warrants tied to cash proceeds - Stock Titan
Price to sales forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to revenue forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to EBIT forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Price to book forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
Enterprise value to EBITDA forward of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView
0.79%
4.39%
자본화:
|
볼륨(24시간):